Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.

MLA

Ho, Shamaine Wei Ting, et al. “Regulatory Enhancer Profiling of Mesenchymal-Type Gastric Cancer Reveals Subtype-Specific Epigenomic Landscapes and Targetable Vulnerabilities.” Gut, vol. 72, no. 2, Feb. 2023, pp. 226–41. EBSCOhost, https://doi.org/10.1136/gutjnl-2021-326483.

APA

Ho, S. W. T., Sheng, T., Xing, M., Ooi, W. F., Xu, C., Sundar, R., Huang, K. K., Li, Z., Kumar, V., Ramnarayanan, K., Zhu, F., Srivastava, S., Isa, Z. F. B. A., Anene-Nzelu, C. G., Razavi-Mohseni, M., Shigaki, D., Ma, H., Tan, A. L. K., Ong, X., … Tan, P. (2023). Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut, 72(2), 226–241. https://doi.org/10.1136/gutjnl-2021-326483

Chicago

Ho, Shamaine Wei Ting, Taotao Sheng, Manjie Xing, Wen Fong Ooi, Chang Xu, Raghav Sundar, Kie Kyon Huang, et al. 2023. “Regulatory Enhancer Profiling of Mesenchymal-Type Gastric Cancer Reveals Subtype-Specific Epigenomic Landscapes and Targetable Vulnerabilities.” Gut 72 (2): 226–41. doi:10.1136/gutjnl-2021-326483.